Can you provide the average price target for XPERI INC stock?
11 analysts have analysed XPER and the average price target is 11.63 USD. This implies a price increase of 100.14% is expected in the next year compared to the current price of 5.81.
NYSE:XPER • US98423J1016
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XPERI INC (XPER).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-01-13 | BWS Financial | Maintains | Buy -> Buy |
| 2025-11-10 | BWS Financial | Maintains | Buy -> Buy |
| 2025-11-06 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-29 | BWS Financial | Maintains | Buy |
| 2025-07-29 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-05-08 | BWS Financial | Maintains | Top Pick -> Top Pick |
| 2025-02-27 | BWS Financial | Maintains | Top Pick -> Top Pick |
| 2025-02-27 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-11-07 | BWS Financial | Maintains | Top Pick -> Top Pick |
| 2024-08-22 | BWS Financial | Maintains | Top Pick -> Top Pick |
| 2024-08-06 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-08-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-09 | BWS Financial | Maintains | Top Pick -> Top Pick |
| 2024-03-01 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-12-13 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-11-14 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-08-10 | Rosenblatt | Reiterate | Buy -> Buy |
| 2023-06-13 | Rosenblatt | Initiate | Buy |
| 2023-02-22 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-02-22 | Maxim Group | Maintains | Buy |
| 2022-10-11 | Maxim Group | Initiate | Buy |
| 2022-10-06 | BWS Financial | Initiate | Top Pick |
| 2022-08-02 | Stephens & Co. | Initiate | Equal-Weight |
| 2022-01-03 | BWS Financial | Upgrade | Buy -> Top Pick |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 521.334M 3.79% | 493.688M -5.30% | 448.105M -9.23% | 466.18M 4.03% | 503.98M 8.11% | 566.1M 12.33% | 713.18M 25.98% | 788.36M 10.54% | |
| EBITDA YoY % growth | -53.53M 1.58% | -29.526M 44.84% | 4.534M 115.36% | 80.879M 1,683.83% | 95.951M 18.64% | 138.41M 44.25% | 161.36M 16.58% | 184.42M 14.29% | |
| EBIT YoY % growth | -127.927M 6.69% | -85.54M 33.13% | -43.731M 48.88% | 63.006M 244.08% | 68.318M 8.43% | N/A | N/A | N/A | |
| Operating Margin | -24.54% | -17.33% | -9.76% | 13.52% | 13.56% | N/A | N/A | N/A | |
| EPS YoY % growth | -0.02 95.89% | 0.97 4,950.00% | 0.79 -18.56% | 1.00 26.37% | 1.24 24.14% | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 -21.38% | 0.10 -11.91% | 0.30 8.68% | 0.42 76.23% | 0.12 -2.70% | 0.06 -36.84% | 0.29 -6.14% | 0.44 3.70% |
| Revenue Q2Q % growth | 110.05M -3.49% | 111.13M 4.91% | 119.64M 7.17% | 125.34M 7.58% | 117.02M 6.33% | 116.33M 4.68% | 129.99M 8.65% | 134.36M 7.20% |
| EBITDA Q2Q % growth | 13.405M 451.56% | 14.299M 1.51% | 24.955M -29.33% | 28.435M -15.04% | 17.59M 31.22% | 16.097M 12.57% | 27.161M 8.84% | 33.44M 17.60% |
| EBIT Q2Q % growth | 11.778M 171.64% | 7.712M 169.27% | 16.705M 1,326.51% | 26.81M 281.20% | 11.873M 0.81% | 8.683M 12.59% | 19.795M 18.50% | 27.967M 4.32% |
All data in USD
11 analysts have analysed XPER and the average price target is 11.63 USD. This implies a price increase of 100.14% is expected in the next year compared to the current price of 5.81.
The consensus EPS estimate for the next earnings of XPERI INC (XPER) is 0.13 USD and the consensus revenue estimate is 110.05M USD.
The number of analysts covering XPERI INC (XPER) is 11.